Stockscreener 앱 받기
1.1299
6.51%
-0.0801
전일 마감가:
$1.21
열려 있는:
$1.27
하루 거래량:
1.29M
Relative Volume:
2.90
시가총액:
$15.69M
수익:
-
순이익/손실:
$-25.56M
주가수익비율:
-0.2173
EPS:
-5.2
순현금흐름:
$-19.35M
1주 성능:
+33.05%
1개월 성능:
+45.96%
6개월 성능:
-53.35%
1년 성능:
-76.93%
1일 변동 폭
$1.12
$1.32
1주일 범위
$0.8177
$1.32
52주 변동 폭
$0.62
$7.50
Biovie Inc Stock (BIVI) Company Profile
명칭
Biovie Inc
전화
775-888-3162
주소
680 W NYE LANE, CARSON CITY
BIVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.12 | 15.69M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.12 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.00 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.78 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.39 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
251.96 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 개시 | B. Riley Securities | Buy |
Biovie Inc 주식(BIVI)의 최신 뉴스
BioVie assembles advisory board for neurodegenerative care - Investing.com
BioVie Unveils Corporate Advisory Board Featuring Neuralink - GlobeNewswire
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth - Yahoo Finance
BioVie (BIVI) Advances Parkinson's Trial with Innovative Drug Bezisterim - GuruFocus
BioVie (BIVI) Advances Key Drug Treatments and Clinical Trials - GuruFocus
Geode Capital Management LLC Buys 85,234 Shares of BioVie Inc. (NASDAQ:BIVI) - Defense World
INVESTOR ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire
INVESTOR ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
BioVie Inc (BIVI) Stock: A Year of Highs and Lows - investchronicle.com
Shareholders That Lost Money on BioVie Inc.(BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of BioVie Inc.(BIVI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Bank of Montreal Can Invests $100,000 in BioVie Inc. (NASDAQ:BIVI) - Defense World
New to The Street Airs on Bloomberg TV Saturday, April 26 at 6:30 PM ET Featuring BioVie (NASDAQ: BIVI), Skip Barber Racing School with CFO Michael Berg, CommercialVille.tv, Sustainable Green Team (OTCPK: SGTM) WaterLess Garden, and The Busin - Cadillac News
BioVie (NASDAQ:BIVI) Trading Down 5.6% – Should You Sell? - Defense World
Financial Contrast: BioVie (NASDAQ:BIVI) vs. DiaMedica Therapeutics (NASDAQ:DMAC) - Defense World
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim In Early Parkinson's Disease - Nasdaq
BioVie (BIVI) Launches Phase 2 SUNRISE-PD Trial for Parkinson's Treatment | BIVI Stock News - GuruFocus
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled - GlobeNewswire
Breakthrough Parkinson's Drug Enters Critical Phase 2 Trial: First Patient Dosed - Stock Titan
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), a - voiceofalexandria.com
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice - Hastings Tribune
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vic - voiceofalexandria.com
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vi - Newswire.com
Constellation Brands Q4 2025 Earnings Call Transcript - MarketBeat
ALERT: Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial Inc. (NASDAQ: VIRT), as Securities Fraud Class - TradingView
UPCOMING BIVI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioVie Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024BIVI - ACCESS Newswire
SECURITIES FRAUD CLASS ACTIONS SURVIVE MOTIONS TO DISMISS: - GlobeNewswire
SECURITIES FRAUD CLASS ACTIONS SURVIVE MOTIONS TO DISMISS: Grabar Law Office Investigates Claims on Behalf of Shareholders of Arqit Quantum Inc. (NASDAQ: ARQQ); Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); a - Morningstar
BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
BioVie (BIVI) Faces Securities Fraud Class Action After Uncovering Potential Scientific Misconduct In Failed Phase 3 Clinical Trial – Hagens Berman - ACCESS Newswire
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events - ACCESS Newswire
Biovie stock hits 52-week low at $0.98 amid sharp annual decline - Investing.com Canada
Biovie stock hits 52-week low at $0.98 amid sharp annual decline By Investing.com - Investing.com South Africa
Biovie Inc (BIVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
0.32%
자본화:
|
볼륨(24시간):